Published: 2018-09-26

Immediate induction of labor in premature rupture of membranes at term (PROMT)-vaginal Misoprostol tablet versus PGE2 gel: a randomized comparative study

Snehamay Chaudhuri, Sankar Nath Mitra, Pradip Kumar Banerjee, Pranab Kumar Biswas, Sudipta Bhattacharrya


Background: The aim of the study is to compare immediate induction with vaginal misoprostol tablet and immediate induction with vaginal PGE2 gel in women with premature rupture of membranes at term (PROMT).

Methods: Nine hundred thirty-two women with PROM at term were assigned randomly to receive intravaginal 25μg misoprostol tablet, 4 hourly with a maximum of 5 doses or 0.5 mg vaginal PGE2 gel 6 hourly with a maximum of 2 doses. The primary outcome measures were cesarean section rate, admission to delivery interval and induction to delivery interval. Secondary outcomes included, mode of delivery, and maternal and neonatal safety outcome. Results were calculated applying Fisher Exact Test, Chi square test, t test and calculating the P-value using an alpha level of 0.05 for Type I error.

Results: The mean time from admission to delivery was 13.16 hours in the misoprostol group and 13.56 hours in the PGE2 group (P= 0.3014). Induction to delivery interval was also comparable between the groups (10.23 h versus 10.18 h).Caesarean section rate did not differ significantly between groups (12.13% versus 15.74% ,P=0.135 RR 0.783 95% CI 0.568-1.079).More women in misoprostol group had instrumental delivery (7.57% versus 4.25%, P=0.031, RR 1.089 95% CI 1.04-3.03).The  neonatal outcomes were comparable between the groups . Maternal outcomes were not significantly different except incidence of analgesic use (P=0.009 RR 1.62 95% CI 1.03-1.30), meconium stained liquor (P=.0096 RR 2.03 CI 1.17-3.53) and   number of digital vaginal examinations (P<.0001) in misoprostol group.

Conclusions: Vaginal misoprostol is equally efficacious in labor induction and demonstrates a similar fetal and maternal safety profile to PGE2 gel.


Dinoprostone, Induction of labor, Misoprostol, PGE2 gel, Premature rupture of membranes at term, PROM

Full Text:



Duff P. Premature rupture of membranes at term. N Engl J Med. 1996;334:1053-4.

George SS, Gangarani VS, Shesadri L. Term PROM-a 12 hour expectant management. J Obstet Gynecol India. 2003;53:230-3.

Mishanina E, Rogozinska E, Thatthi T, Uddin-Khan R, Khan KS, Meads C. Use of labour induction and risk of cesarean delivery: a systematic review and metanalysis. CMAJ. 2014;186(9):665-73.

Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et al. Induction of labor compared with expectant management of labor for prelabor rupture of membranes at term. N Eng J Med. 1996;334:1005-10.

Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Dias S, Jones LV, et al. Labour induction with prostaglandins: systematic review and network meta-analysis. BMJ. 2015;350:h217.

Chaudhuri S, Mitra SN, Biswas PK, Bhattacharyya S. Premature rupture of membranes at term: immediate induction with PGE2 gel compared with delayed induction with oxytocin. J Obstet Gynecol India. 2006;56(3):224-9.

Carbonne B, Goffinet F, Cabrol D. Vaginal administration prostaglandin E2 in premature ruptured membranes at term with an unfavorable cervix. J Gynecol Obstet Biol Reprod. 1996;25(8):783-91.

Larranaga-Azcarate C, Campo- Molina G, Perez- Ridriguez AF, Ezcurdia- Gurpedui M. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes. Acta Obstet Gynecol Scand. 2008;87(2):195-200.

Ben-Haroush A, Yogev Y, Glickman H. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2. Am J Peinatol. 2004;21:263-8.

Chaudhuri S, Mitra SN, Banerjee PK, Biswas PK, Bhattacharyya S. Comparison of vaginal misoprostol tablets and prostaglandin E2 gel for the induction of labor in premature rupture of membranes at term: A randomized comparative trial. J Obstet Gynaecol Res. 2011;37(11):1564-71.

Wing DA, Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Am J Obst Gynecol. 1998;179(1):94-9.

Zeteroglu S, Eugin- Ustin Y, Guvercinci M, Sahin G, Kamaci M. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term. J Matern Fetal Neonatal Med. 2006;19(5):283-7.

Krupa FDG, Cecatto GJ, Surita FGC, Milanez HMBP, Parpinelli MA. Misoprostol versus expectant management in premature rupture of membranes at term. BJOG. 2005;112:1284-90.

Nanda S, Singhal SR, Papneja A. Induction of labour with intravaginal misoprostol and prostaglandin E2 gel: a comparative study. Trop Doct. 2007;37(1):21-4.

Prager M, Enorth-Gimfors E, Edlund M, Marions L. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labor induction. BJOG. 2008;115(11):1443-50.

Calder AA, Loughney AD, Weir CJ, Barber JW. Induction of labor in nulliparous and multiparous women: a UK, multicentre, open-label study of intravaginal misoprostol in comparison with dinoprostone. BJOG. 2008;115(10):1279-88.